Brevundimonas diminuta is the test organism specified in the United States Environmental Protection Agency's (USEPA) reverse osmosis (RO) treatment device verification protocol. As nonselective growth medium is employed, enumeration of B. diminuta may be impaired due to interference by indigenous heterotrophic bacteria. Thus the microbial removal capability of the filtration system may be incorrectly assessed. As these treatment devices are used in emergency situations, the health of the public could be compromised. The objective of this study was to develop selective approaches for enumerating viable B. diminuta in test water. Two molecular approaches were investigated: expression of a kanamycin resistance gene and expression of a fluorescent protein gene. The USEPA protocol specifies a 0.3 μm cell size, so the expression of the selective markers were assessed following growth on media designed to induce this small cell diameter. The kan R strain was demonstrated to be equivalent to the wild type in cell dimension and survival following exposure to the test water. The kan R strain showed equivalent performance to the wild type in the RO protocol indicating that it is a viable alternative surrogate. By utilizing this strain, a more accurate validation of the RO system can be achieved.
INTRODUCTION
Membrane technologies are among the most versatile water treatment processes with regard to their ability to effectively remove a wide variety of contaminants (Madaeni ) . The objective of this study was to develop selective methodology for the enumeration of viable B. diminuta ATCC 19146 while using R2A as the growth medium. As some treatment devices incorporate antimicrobials within their systems in conjunction with RO, it is desirable for these applications to know the surviving fraction of the test organisms. A direct electroporation approach was investigated to confer kanamycin resistance and expression of two novel fluorescent protein vectors to B. diminuta (pAcGFP1 and pDsRedMonomer). The recombinant strains were compared to the wild type (wt) B. diminuta strain in respect to cell size, growth, and expression on R2A, and survival in the test water specified by the USEPA RO protocol. Ultimately the kanamycin resistant strain was subjected to a side-by-side analysis with the wt B. diminuta in the USEPA RO protocol using commercially available devices.
MATERIALS AND METHODS

Media and reagents
All media used for the isolation and growth of the organisms detailed in this study were from Difco (Becton Dickenson, Franklin Lakes, NJ, USA). All reagents and chemicals used in this set of experiments were ACS reagent grade or higher (Sigma Aldrich, St. Louis, MO, USA).
Bacterial strains
The challenge organism, B. diminuta ATCC 19146, was 
Test system for water treatment devices
A test system was constructed to evaluate the filtration efficiency of RO devices. The system specifications and verification protocol were developed by NSF International in collaboration with the USEPA as part of the ETV program (USEPA a, b). The system was designed to accommodate devices possessing flow rates ranging from 1.9 to 100 L per min. A schematic of the test system is provided in Figure 1 .
The test system utilized a 2,000 L polyethylene tank to hold the influent test water (challenge water). The electroporation event and cell recovery were performed as described in the transformation section with the exception that the transformants were plated on LB agar amended with reverse osmosis, and deionization to make the base water for the tests
Water characteristics Specification
Alkalinity (as CaCO 3 ) 100 ± 10 mg/L pH 7.5 ± 0.5 pH
Total organic carbon <100 CFU per mL 50 μg/mL ampicillin. Individual colonies were screened for expression of the fluorescent proteins using a fluorescent microscope equipped with FITC (excitation 475 nm, emission ¼ 505 nm) and rhodamine (excitation 557 nm, emission ¼ 585 nm) filter sets.
As the EPA protocol calls for R2A to be utilized as the growth media for all influent and effluent test samples, expression of the GFP and RFP on R2A agar was also investigated. The recombinant strains, grown previously in SLB for 48 h at 30 W C, were plated on R2A agar with and without ampicillin amendment.
Confirmation of gene expression
To establish that the vectors had been incorporated into 
Long-term expression of kanamycin resistance
The stability of the kan R strain in expressing kanamycin resistance was assessed over a 1-year period. Multiple suspensions of kan R at a concentration of 1 × 10 8 CFU per mL were created in sterile phosphate-buffered saline. The suspensions were held at 4 W C for 1 year and the cell density was evaluated for the suspensions twice monthly. The ability of kan R to express kanamycin resistance post resuscitation from À70 W C storage in a glycerol suspension was also evaluated quarterly over the period of 1 year. For all of the sampling events, the kan R strain suspensions were diluted in sterile phosphate-buffered saline and the dilutions were spread plated on R2A agar amended with 50 μg/mL of kanamycin.
Affect of test water characteristics on kan R
The viability of the kan R strain and the B. diminuta wt strain was evaluated after a 6 h exposure to test waters possessing the following abiotic parameters: temperatures of 4 and 20 W C; and total dissolved solids (TDS) of 5 and 500 mg/L.
To assess the impact of the test water on low, medium, and high bacterial loads, concentrations ranging from 10 2 to 10 6 CFU per mL were included. These cell concentrations simulated varying magnitudes of bacterial contamination that may be accidentally or intentionally introduced into a water distribution system. Aliquots were removed every 2 h and enumeration of the challenge organisms was accomplished via spread plating on R2A agar (kan R samples were plated on R2A amended with 50 μg/mL of kanamycin). All plates were incubated for 48 h at 30 W C.
Performance of B. diminuta wild type and kan R strains in USEPA RO treatment device evaluation test
The wt and kan R strains of B. diminuta ATCC 19146 were evaluated against the USEPA RO validation protocol. Three separate RO devices from two different manufacturers were included in the evaluation. These devices possessed a rated service flow of approximately 6 L/min. The systems were conditioned according to the vendor's instructions using the USEPA base test water at pH 7.5 ± 0.5. At the end of the conditioning procedure, treated water samples were collected from each system as negative controls and analyzed for the challenge organisms. The RO membranes were operated using the base test water for 5 more days prior to challenge testing to ensure that they were performing optimally.
Following the conditioning period, the RO membranes were challenged with the wt and kan R strains. The pH of the test water was 7.5. Cellular concentrations of 1 × 10 6 CFU/100 mL were targeted for each bacterial test strains. A 2 L bacterial suspension was prepared for both strains using SLB as the growth medium and the following incubation conditions: temperature of 30 W C; incubation time of 48 h;
shaking at 150 rpm. For growth of the kan R strain, the SLB was amended with 50 μg/mL of kanamycin. After addition of the test organism, the test water was mixed for a minimum of 30 min using a recirculation pump prior to beginning the test. After all systems were shut off, the RO water storage tanks were emptied into separate sterile containers and 1 L samples were collected in sterile polypropylene bottles for challenge organism enumeration. All samples and accompanying dilutions were enumerated in triplicate using the membrane filtration method (0.1 μm pore-size cellulose filter). The membranes were aseptically transferred to the appropriate growth agar. R2A agar was used for growth of the wt and R2A agar amended with 50 μg/mL of kanamycin was used for kan R . All plates were incubated for 48 h at 30 W C.
Statistical analysis
Two-tailed Student t-tests (α ¼ 0.05) were used for comparing the survival of the wt and kan R strain after exposure to the varying test water parameters. Microsoft Office Excel 2000 (Microsoft Corp.) was used to perform the Student t-tests.
RESULTS AND DISCUSSION
Transformation studies to confer selectivity to B. diminuta
In contrast to previous studies that incorporated an E. coli 
).
Validation of the kan R strain as a suitable challenge organism Studies were performed to assess the stability of the recombinant kan R strain when exposed to the varying abiotic conditions of the test water specified in the USEPA RO validation protocol. During the RO device verification test, the challenge organism must be able to remain viable and maintain stable cell densities for the duration of the test. Performance of kan R in the USEPA RO protocol
In this study the kan R strain has been shown to be similar to the wt strain in terms of size expression and its ability to remain viable over an extended period of time when exposed to the test water. Therefore, a side-by-side evaluation of the two strains using the USEPA RO treatment device verification protocol was performed. Different RO models were included in the test evaluation since the protocol was designed to be independent and applicable to all makes or models of RO treatment devices. The results of the evaluation are provided in Table 3 . For all test runs, the minimum target influent concentration of 1 × 10 6 CFU/ 100 mL was achieved for both the wild type and recombinant B. diminuta strain. The treatment devices varied in their ability to remove B. diminuta from the challenge water. Device 2 displayed the greatest removals (>7 log). 
CONCLUSION
This was the first known study to utilize a recombinant B. diminuta strain that was resistant to kanamycin in the verification of the performance of a RO treatment device.
The experiments demonstrated that the Tn5 vector was successfully integrated into B. diminuta ATCC 19146 and that its expression is stable and robust. The viability of this strain was stable at a wide range of temperatures, pH, and TDS. The strain also achieved the strict size requirements of the protocol. The recombinant strain was found to be equivalent in performance to its wt counterpart when testing against the USEPA RO protocol. The selectivity characteristics of the recombinant B. diminuta kan R strain allowed for a more accurate assessment of the removal efficiency of RO treatment devices. In addition, the use of this selective strain could be applied to other membrane filtration verification protocols which utilize B. diminuta as the test organism. As a genetically engineered strain is being proposed for future use in the ETV RO protocol, appropriate monitoring and disinfection procedures should be implemented to ensure that this strain is not released into the environment. Ultimately, the development of a more precise evaluation method for these devices will benefit public health by ensuring that the systems validated for drinking water production can meet their stated microbial removal claims.
